D Vanhee, P Gosset, B Wallaert, C Voisin and AB Tonnel
Laboratoire de Pathologie Immunoallergique Respiratoire et Cellules Inflammatoires, INSERM Unite 416, Institut Pasteur, Lille, France.

To identify the clinical relevance of cytokines involved in the development of lung fibrosis observed in patients with coal workers' pneumoconiosis (CWP), we investigated the BAL fluid contents and AM secretions of three mediators that modulate fibroblast growth: platelet- derived growth factor (PDGF), Type I insulin-like growth factor (IGF- I), and transforming growth factor Type beta (TGF-beta). Our study population consisted of 25 patients with CWP (16 simple pneumoconiosis, SP, 9 progressive massive fibrosis, PMF, 9 control subjects, and 6 patients with idiopathic pulmonary fibrosis (IPF). The fibrotic potency of AM supernatants was also tested for their ability to promote the growth of a human lung fibroblast cell line appreciated by [3H]- thymidine incorporation. PDGF and IGF-I concentrations were increased in BAL fluids of patients with PMF compared with SP and control subjects, whereas TGF-beta concentration was significantly higher in BAL fluid of patients with SP compared with PMF and control subjects. PDGF, IGF-I, and TGF-beta concentrations in AM supernatants followed the same profile observed in BAL fluids, suggesting that AM is one of the main cell sources of PDGF, IGF-I, and TGF-beta in the lung of pneumoconiotic patients. After treatment by acidification, which activated the latent form of TGF-beta, AM from patients with SP induced an inhibition of [3H]-thymidine incorporation and fibroblast growth was restored after neutralization of TGF-beta by specific antibodies. In contrast, AM supernatants from patients with PMF and IPF promoted the proliferation of fibroblasts and treatment by acidification did not modify this effect.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				B. Yucesoy, V. J. Johnson, G. E. Kissling, K. Fluharty, M. L. Kashon, J. Slaven, D. Germolec, V. Vallyathan, and M. I. Luster Genetic susceptibility to progressive massive fibrosis in coal miners Eur. Respir. J., June 1, 2008; 31(6): 1177 - 1182. [Abstract] [Full Text] [PDF]

				E. Hsu and C. A. Feghali-Bostwick Insulin-Like Growth Factor-II Is Increased in Systemic Sclerosis-Associated Pulmonary Fibrosis and Contributes to the Fibrotic Process via Jun N-Terminal Kinase- and Phosphatidylinositol-3 Kinase-Dependent Pathways Am. J. Pathol., June 1, 2008; 172(6): 1580 - 1590. [Abstract] [Full Text] [PDF]

				O. C. Ulker, B. Yucesoy, M. Durucu, and A. Karakaya Neopterin as a marker for immune system activation in coal workers' pneumoconiosis. Toxicology and Industrial Health, April 1, 2007; 23(3): 155 - 160. [Abstract] [PDF]

				J. L. Chunn, J. G. Molina, T. Mi, Y. Xia, R. E. Kellems, and M. R. Blackburn Adenosine-Dependent Pulmonary Fibrosis in Adenosine Deaminase-Deficient Mice J. Immunol., August 1, 2005; 175(3): 1937 - 1946. [Abstract] [Full Text] [PDF]

				S. K. Frankel, B. M. Moats-Staats, C. D. Cool, M. W. Wynes, A. D. Stiles, and D. W. H. Riches Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L805 - L812. [Abstract] [Full Text] [PDF]

				J. M. Pilewski, L. Liu, A. C. Henry, A. V. Knauer, and C. A. Feghali-Bostwick Insulin-Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition Am. J. Pathol., February 1, 2005; 166(2): 399 - 407. [Abstract] [Full Text] [PDF]

				P. Misson, S. van den Brule, V. Barbarin, D. Lison, and F. Huaux Markers of macrophage differentiation in experimental silicosis J. Leukoc. Biol., November 1, 2004; 76(5): 926 - 932. [Abstract] [Full Text] [PDF]

				D. J. Lalor, B. Truong, S. Henness, A. E. Blake, Q. Ge, A. J. Ammit, C. L. Armour, and J. M. Hughes Mechanisms of serum potentiation of GM-CSF production by human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1007 - L1016. [Abstract] [Full Text] [PDF]

				U. Bartram and C. P. Speer The Role of Transforming Growth Factor {beta} in Lung Development and Disease Chest, February 1, 2004; 125(2): 754 - 765. [Abstract] [Full Text] [PDF]

				M. W. Wynes and D. W. H. Riches Induction of Macrophage Insulin-Like Growth Factor-I Expression by the Th2 Cytokines IL-4 and IL-13 J. Immunol., October 1, 2003; 171(7): 3550 - 3559. [Abstract] [Full Text] [PDF]

				O Kayacan, S Beder, and D Karnak Cellular profile of bronchoalveolar lavage fluid in Turkish miners Postgrad. Med. J., September 1, 2003; 79(935): 527 - 530. [Abstract] [Full Text]

				P. M. Krein, P. J. B. Sabatini, W. Tinmouth, F. H. Y. Green, and B. W. Winston Localization of Insulin-like Growth Factor-I in Lung Tissues of Patients with Fibroproliferative Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 83 - 90. [Abstract] [Full Text] [PDF]

				F. Huaux, M. Arras, D. Tomasi, V. Barbarin, M. Delos, J.-P. Coutelier, A. Vink, S. H. Phan, J.-C. Renauld, and D. Lison A Profibrotic Function of IL-12p40 in Experimental Pulmonary Fibrosis J. Immunol., September 1, 2002; 169(5): 2653 - 2661. [Abstract] [Full Text] [PDF]

				C. A. BLOOR, R. A. KNIGHT, R. K. KEDIA, M. A. SPITERI, and J. T. ALLEN Differential mRNA Expression of Insulin-like Growth Factor-1 Splice Variants in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 265 - 272. [Abstract] [Full Text] [PDF]

				B. Nemery, A. Bast, J. Behr, P.J.A. Borm, S.J. Bourke, Ph. Camus, P. De Vuyst, H.M. Jansen, V.L. Kinnula, D. Lison, et al. Interstitial lung disease induced by exogenous agents: factors governing susceptibility Eur. Respir. J., July 1, 2001; 18(32_suppl): 30S - 42s. [Abstract] [Full Text] [PDF]

				P.J.A. Borm and R.P.F. Schins Genotype and phenotype in susceptibility to coal workers' pneumoconiosis. The use of cytokines in perspective Eur. Respir. J., July 1, 2001; 18(32_suppl): 127S - 133s. [Abstract] [Full Text] [PDF]

				V. VALLYATHAN, M. GOINS, L. N. LAPP, D. PACK, S. LEONARD, X. SHI, and V. CASTRANOVA Changes in Bronchoalveolar Lavage Indices Associated with Radiographic Classification in Coal Miners Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 958 - 965. [Abstract] [Full Text]

				J.-M. CHARPIN, M. STERN, D. GRENET, and D. ISRAËL-BIET Insulinlike Growth Factor-1 in Lung Transplants with Obliterative Bronchiolitis Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1991 - 1998. [Abstract] [Full Text]

				C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF]

				S.-T. UH, Y. INOUE, T. E. KING Jr., E. D. CHAN, L. S. NEWMAN, and D. W. H. RICHES Morphometric Analysis of Insulin-like Growth Factor-I Localization in Lung Tissues of Patients with Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1626 - 1635. [Abstract] [Full Text] [PDF]

				B. Y. Chin, M. E. Choi, M. D. Burdick, R. M. Strieter, T. H. Risby, and A. M. K. Choi Induction of apoptosis by particulate matter: role of TNF-alpha and MAPK Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L942 - L949. [Abstract] [Full Text] [PDF]

				G. Gurujeyalakshmi, M. A. Hollinger, and S. N. Giri Regulation of Transforming Growth Factor-beta 1 mRNA Expression by Taurine and Niacin in the Bleomycin Hamster Model of Lung Fibrosis Am. J. Respir. Cell Mol. Biol., March 1, 1998; 18(3): 334 - 342. [Abstract] [Full Text]